Masso Torrence Wealth Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Masso Torrence Wealth Management’s Portfolio CRVS Stock Details CRVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$200K	Buy
2025 Q1	$111K	Buy
2024 Q4	$161K	Buy
2024 Q3	$52.8K	Hold
2024 Q2	$18.2K	Hold
2024 Q1	$17.8K	Hold
2023 Q4	$17.6K	Hold
2023 Q3	$14.6K	Buy
2022 Q1	–	Sell
2021 Q4	$7K	Buy